YCombinator

Origami Therapeutics is now on Y Combinator! Learn more about Y Combinator Funded...

Attacking Neurodegenerative Diseases with Protein Degraders

The use of protein degraders is a promising area of emerging small molecule therapies. Rather than inhibit disease-causing proteins, degraders use a natural cellular process to break them down. Origami Therapeutics is using its proprietary drug discovery platform to...